Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2064791000168113 | ropivacaine hydrochloride 20 mg / 10 mL injection, 5 x 10 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2064801000168114 | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | has MPUU | ropivacaine hydrochloride 20 mg/10 mL injection, ampoule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naropin 0.2% 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | True | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Inferred relationship | Some | |
| Ropivacaine 0.2% (Actavis) 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | True | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Inferred relationship | Some | |
| Ropibam 0.2% 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | True | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Inferred relationship | Some | |
| Ropivacaine 0.2% (Kabi) 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | True | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Inferred relationship | Some | |
| Ropivacaine (Sandoz) 20 mg/10 mL injection, 5 x 10 mL ampoules | Is a | True | ropivacaine hydrochloride 20 mg/10 mL injection, 5 x 10 mL ampoules | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR